Agneta Svedberg
Patrimonio netto: 1 M $ in data 31/05/2026
Patrimonio netto: 1 M $ in data 31/05/2026
Agneta Svedberg is currently working as the VP-Clinical Development & Pharmacovigilance at Camurus AB since 2015.
Prior to this, she held positions as the Chief Executive Officer at Cantargia AB, Manager at Pharmacia & Upjohn, Inc., Principal at Oncotelic Therapeutics, Inc., Chief Operating Officer & Senior Vice President at Zealand Pharma A, and Senior Vice President-Clinical Development at Genmab, Inc. Ms. Svedberg has a graduate degree from the University of Lund and holds an MBA from Lund University School of Economics & Management and Executive Foundation Lund.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CAMURUS AB 0,04% | 15/09/2025 | 22.987 ( 0,04% ) | 1 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CAMURUS AB | Direttore Tecnico/Scientifico/R&S | - |
| Società | Posizione | Fine |
|---|---|---|
| CANTARGIA AB | Amministratore Delegato | - |
| ZEALAND PHARMA A/S | Direttore operativo | - |
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Pharmacia & Upjohn, Inc.
Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Corporate Officer/Principal | - |
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Pharmacia & Upjohn, Inc.
Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Oncotelic Therapeutics, Inc.
Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Camurus AB
Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Commercial Services |
Cantargia AB
Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Lund University School of Economics & Management
Lund University School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Executive Foundation Lund
Executive Foundation Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale